Literature DB >> 23377827

Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.

Zhiwen Liu1, Xiaohui Jia, Yijie Duan, Huijie Xiao, Karl-Gösta Sundqvist, Johan Permert, Feng Wang.   

Abstract

Pancreatic cancer patients frequently show hyperglycemia, but it is uncertain whether hyperglycemia stimulates pancreatic cancer cells. We have investigated whether excess glucose induces hypoxia-inducible factor-1α (HIF-1α) and stimulates glucose metabolism and cell migration in pancreatic cancer cells. We studied wild-type (wt) MiaPaCa2 pancreatic cancer cells and a MiaPaCa2 subline (namely si-MiaPaCa2) that had HIF-1α-specific small interfering RNA. Wt-MiaPaCa2 cells are known to be HIF-1α-positive in hypoxia and HIF-1α-negative in normoxia, whereas si-MiaPaCa2 cells are devoid of HIF-1α in both normoxia and hypoxia. We incubated these cells with different amounts of glucose and determined HIF-1α mRNA and protein by real-time polymerase chain reaction and western blotting. We determined glucose consumption, lactate production and intracellular hexokinase-II and ATP to assess glucose metabolisms and determined pyruvate dehydrogenase kinase-1, reactive oxygen species and fumarate to assess mitochondrial activities. Further, we studied cell migration using a Boyden chamber. Excess glucose (16.7-22.2mM) increased HIF-1α in hypoxic wt-MiaPaCa2 cells. HIF-1α expression increased ATP contents and inhibited mitochondrial activities. Extracellular glucose and hypoxia stimulated glucose metabolisms independent of HIF-1α. Excess glucose stimulated the migration of wt- and si-MiaPaCa2 cells in both normoxia and hypoxia. Thus, glucose stimulated cell migration independent of HIF-1α. Nevertheless, hypoxic wt-MiaPaCa2 cells showed greater migrating ability than their si-MiaPaCa2 counterparts. We conclude that (1) excess glucose increases HIF-1α and ATP in hypoxic wt-MiaPaCa2 cells, (2) extracellular glucose and hypoxia regulate glucose metabolisms independent of HIF-1α and (3) glucose stimulates cell migration by mechanisms that are both dependent on HIF-1α and independent of it.

Entities:  

Keywords:  cell migration; glucose; glycolysis; hexokinase-II; hypoxia-inducible factor-1; pancreatic cancer; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 23377827      PMCID: PMC3672187          DOI: 10.4161/cbt.23786

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  25 in total

1.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.

Authors:  S Salceda; J Caro
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.

Authors:  Ryo Fukuda; Kiichi Hirota; Fan Fan; Young Do Jung; Lee M Ellis; Gregg L Semenza
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

5.  Pancreatic cancer is associated with impaired glucose metabolism.

Authors:  J Permert; I Ihse; L Jorfeldt; H von Schenck; H J Arnqvist; J Larsson
Journal:  Eur J Surg       Date:  1993-02

6.  Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells.

Authors:  Eva C Vaquero; Mouad Edderkaoui; Stephen J Pandol; Ilya Gukovsky; Anna S Gukovskaya
Journal:  J Biol Chem       Date:  2004-05-23       Impact factor: 5.157

7.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

8.  Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway.

Authors:  John R Griffiths; Paul M J McSheehy; Simon P Robinson; Helen Troy; Yuen-Li Chung; Russell D Leek; Kaye J Williams; Ian J Stratford; Adrian L Harris; Marion Stubbs
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

9.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

Authors:  P H Maxwell; G U Dachs; J M Gleadle; L G Nicholls; A L Harris; I J Stratford; O Hankinson; C W Pugh; P J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

10.  Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin.

Authors:  Mohd Askandar Iqbal; Rameshwar N K Bamezai
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more
  23 in total

Review 1.  Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.

Authors:  Archana Bhaw-Luximon; Dhanjay Jhurry
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-09       Impact factor: 4.553

2.  Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signaling.

Authors:  Guangxia Chen; Wan Feng; Shu Zhang; Kangqi Bian; Yan Yang; Cheng Fang; Min Chen; Jun Yang; Xiaoping Zou
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

3.  Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability.

Authors:  Dapeng Zhang; Lihua Cui; Shu Shun Li; Feng Wang
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

4.  HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Authors:  Na-Na Tang; Hong Zhu; Hong-Jie Zhang; Wei-Feng Zhang; Hai-Lin Jin; Lu Wang; Pin Wang; Gui-Jun He; Bo Hao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Impact of high glucose on metastasis of colon cancer cells.

Authors:  Cheng-Yao Lin; Chih-Hui Lee; Chien-Cheng Huang; Song-Tay Lee; How-Ran Guo; Shih-Bin Su
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 6.  Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Authors:  Oleksandr H Minchenko; Katsuya Tsuchihara; Dmytro O Minchenko; Andreas Bikfalvi; Hiroyasu Esumi
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

8.  Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.

Authors:  İrem Bayar; Ayşegül Bildik
Journal:  Cytotechnology       Date:  2021-02-20       Impact factor: 2.058

Review 9.  High glucose: an emerging association between diabetes mellitus and cancer progression.

Authors:  Suangson Supabphol; Wunchana Seubwai; Sopit Wongkham; Charupong Saengboonmee
Journal:  J Mol Med (Berl)       Date:  2021-05-26       Impact factor: 4.599

Review 10.  Metabolism addiction in pancreatic cancer.

Authors:  R Blum; Y Kloog
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.